LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more
LifeTech Scientific Corporation - Asset Resilience Ratio
LifeTech Scientific Corporation (LFTSF) has an Asset Resilience Ratio of 11.48% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how LifeTech Scientific Corporation's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down LifeTech Scientific Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $612.37 Million | 11.48% |
| Total Liquid Assets | $612.37 Million | 11.48% |
Asset Resilience Insights
- Moderate Liquidity: LifeTech Scientific Corporation has 11.48% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
LifeTech Scientific Corporation Industry Peers by Asset Resilience Ratio
Compare LifeTech Scientific Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for LifeTech Scientific Corporation (2012–2024)
The table below shows the annual Asset Resilience Ratio data for LifeTech Scientific Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 10.53% | $516.13 Million | $4.90 Billion | +6.27pp |
| 2023-12-31 | 4.26% | $200.00 Million | $4.70 Billion | -6.96pp |
| 2021-12-31 | 11.22% | $357.11 Million | $3.18 Billion | +5.43pp |
| 2020-12-31 | 5.79% | $170.99 Million | $2.95 Billion | +2.97pp |
| 2019-12-31 | 2.82% | $50.00 Million | $1.77 Billion | +2.49pp |
| 2018-12-31 | 0.33% | $5.00 Million | $1.53 Billion | -1.34pp |
| 2014-12-31 | 1.67% | $9.44 Million | $566.29 Million | +0.42pp |
| 2013-12-31 | 1.25% | $6.50 Million | $519.98 Million | +0.08pp |
| 2012-12-31 | 1.17% | $4.25 Million | $364.15 Million | -- |